XBiotech, Inc. (XBIT)
2.20
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
2.20
0.00 (0.00%)
After-Hours: 20:00
XBiotech Total Liabilities (Quarterly) : 5.19M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.19M |
| March 31, 2026 | 4.819M |
| December 31, 2025 | 9.91M |
| September 30, 2025 | 5.344M |
| June 30, 2025 | 5.618M |
| March 31, 2025 | 7.151M |
| December 31, 2024 | 16.82M |
| September 30, 2024 | 17.74M |
| June 30, 2024 | 18.85M |
| March 31, 2024 | 18.58M |
| December 31, 2023 | 8.397M |
| September 30, 2023 | 6.94M |
| June 30, 2023 | 6.073M |
| March 31, 2023 | 5.216M |
| December 31, 2022 | 7.361M |
| September 30, 2022 | 6.025M |
| June 30, 2022 | 10.67M |
| March 31, 2022 | 5.243M |
| December 31, 2021 | 6.883M |
| September 30, 2021 | 5.362M |
| June 30, 2021 | 5.392M |
| March 31, 2021 | 3.842M |
| December 31, 2020 | 5.857M |
| September 30, 2020 | 7.254M |
| June 30, 2020 | 15.19M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.29M |
| December 31, 2019 | 61.69M |
| September 30, 2019 | 2.021M |
| June 30, 2019 | 2.462M |
| March 31, 2019 | 2.841M |
| December 31, 2018 | 2.947M |
| September 30, 2018 | 2.307M |
| June 30, 2018 | 2.768M |
| March 31, 2018 | 2.45M |
| December 31, 2017 | 2.81M |
| September 30, 2017 | 3.522M |
| June 30, 2017 | 4.685M |
| March 31, 2017 | 5.346M |
| December 31, 2016 | 7.986M |
| September 30, 2016 | 6.663M |
| June 30, 2016 | 10.40M |
| March 31, 2016 | 6.583M |
| December 31, 2015 | 6.308M |
| September 30, 2015 | 4.97M |
| June 30, 2015 | 2.872M |
| March 31, 2015 | 3.828M |
| December 31, 2014 | 3.147M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 133.65M |
| Shareholders Equity (Quarterly) | 128.46M |
| Current Ratio | 33.15 |